|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07H 19/06 | |
| A61K 31/7072 | |||
| A61P 31/12 | |||
| C07H 19/073 |
| (11) | Patento numeris | 1534727 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03767281.3 |
| Europos patento paraiškos padavimo data | 2003-08-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-06-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-11-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2003/024987 |
| Data | 2003-08-06 |
| (87) | Numeris | WO 2004/012687 |
| Data | 2004-02-12 |
| (30) | Numeris | Data | Šalis |
| 401318 P | 2002-08-06 | US |
| (72) |
STORER, Richard, GB
JONAITIS, David, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITIONS OF CRYSTALLINE BETA-L-2`-DEOXYTHYMIDINE |
| PHARMACEUTICAL COMPOSITIONS OF CRYSTALLINE BETA-L-2`-DEOXYTHYMIDINE |